摘要:
Cholesteryl ester transfer protein inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.
摘要:
Cholesteryl ester transfer protein inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.
摘要:
A wearable device for reducing exposure to pathogens of possible contagion includes a detection component configured to detect a proximate subject in relation to a user wherein the user is in possession of the wearable device, a data input component configured to capture data relating to the proximate subject, wherein the data relating to the currently proximate subject further comprises an inoculation status of the currently proximate subject, a processor configured to calculate a degree of transmission threat between the user and the proximate subject, wherein calculating the degree of transmission threat further comprises identifying a pathogen of possible contagion, locating a reproduction rate for the pathogen of possible contagion, calculating the degree of transmission threat as a function of the data input component and the reproduction rate, and a user-signaling component configured to generate an output as a function of the degree of transmission threat.
摘要:
Audio systems for a vehicle and methods for increasing auditory situation awareness in a vehicle are provided. An audio system includes at least one ambient microphone disposed on the vehicle, a processor and at least one loudspeaker. The at least one ambient microphone is configured to capture ambient sound external to the vehicle and to produce an ambient sound signal. The processor is configured to receive the ambient sound signal and an audio content signal, and to mix the ambient sound signal with the audio content signal to generate a mixed output signal. The at least one loudspeaker is configured to reproduce the mixed output signal in the vehicle cabin.
摘要:
Audio systems for a vehicle and methods of operating an audio device in a vehicle cabin are provided. A method of operating an audio device directs an acoustic signal to at least one vehicle cabin receiver (VCR) of the audio device; measures sound pressure levels (SPLVCM) for acoustic energy received by at least one vehicle cabin microphone (VCM) of the audio device during a time period Δt; calculates a sound pressure level (SPL) dose (SPL_DoseΔt) during the time period Δt using the sound pressure levels SPLVCM of the at least one VCM; combines the SPL dose (SPL_DoseΔt) with an SPL dose of a previous time period to form a total SPL dose (SPL_Dosetotal); and performs an action to modify operation of the audio device when the total SPL dose is greater than a predetermined threshold.
摘要:
At least one exemplary embodiment is directed to a method of operating an audio device comprising: calculating estimated sound pressure levels for drive signals directed to an ear canal receiver (ECR) during a time increment Δt; calculating an estimated SPL_Dose during the time increment Δt using the estimated sound pressure levels; and calculating a total SPL_Dose at the time t of the audio device using the estimated SPL_Dose.
摘要:
A system for monitoring sound pressure levels at the ear includes an ambient sound microphone for receiving ambient sounds and an ear canal microphone for producing audio signals as a function of ambient sound received at the ambient sound microphone and sound signal received from an associated personal audio device. A logic circuit is operatively associated with the ASM and ECR calculates a total SPL_Dose experienced by the ear at a time t. In one exemplary embodiment the total SPL_Dose is calculated by determining estimated SPL_Dose for periods Δt. The logic circuit then may then select an action parameter in response to the Total SPL_Dose.
摘要:
The invetion relates to compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, R7 and R8 are as defined in the description, their use as medicament, pharmaceutical compositions containing them and processes for their preparation.
摘要:
A method of treating hyperproliferation diseases in mammals in need of such treatment which method includes administering to said mammal a therapeutically effective amount of a compound of the formula: or a pharmaceutically acceptable salt, hydrate or prodrug thereof, wherein R1, R2, R3, R4, W, X, Y, Z and t are as defined herein.
摘要:
There are disclosed preparative processes and hypoglycemic compounds of the formula ##STR1## wherein R is hydrogen or C1 to C3 alkyl;R.sup.1 and R.sup.2 are taken together and are carbonyl; or R.sup.1 and R.sup.2 are taken separately, wherein R.sup.1 is hydrogen or R.sup.4 and R.sup.2 is--COR.sup.5 and COOR.sup.5 ;R.sup.3, R.sup.4 and R.sup.5 are each independently C1 to C9 alkyl, C3 to C7 cycloalkyl, phenyl, naphthyl, furyl, benzofuryl or thienyl or one of said groups mono- or disubstituted with C1 to C3 alkyl, C1 to C3 alkoxy, C1 to C3 alkoxy-carbonyl, trifluoromethyl, fluoro or chloro; and n is 0 or 1; or pharmaceutically acceptable cationic salts thereof.